Cargando…
Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury
The peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist rosiglitazone inhibits NF-κB expression and endogenous neural stem cell differentiation into neurons and reduces the inflammatory cascade after spinal cord injury (SCI). The aim of this study was to explore the mechanisms underlyi...
Autores principales: | Meng, Qing-qi, Lei, Wei, Chen, Hao, Feng, Zhen-cheng, Hu, Li-qiong, Zhang, Xing-liang, Li, Siming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032969/ https://www.ncbi.nlm.nih.gov/pubmed/30034460 http://dx.doi.org/10.1155/2018/3897478 |
Ejemplares similares
-
Combination of methylprednisolone and rosiglitazone promotes recovery of neurological function after spinal cord injury
por: Li, Xi-gong, et al.
Publicado: (2016) -
Rosiglitazone Ameliorates Spinal Cord Injury via Inhibiting Mitophagy and Inflammation of Neural Stem Cells
por: Meng, Qingqi, et al.
Publicado: (2022) -
Does the intrathecal propofol have a neuroprotective effect on spinal cord ischemia?
por: Sahin, Murat, et al.
Publicado: (2015) -
Progress in heterologous biosynthesis of forskolin
por: Ju, Haiyan, et al.
Publicado: (2021) -
Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats
por: Hou, Qing-Xian, et al.
Publicado: (2016)